A previous examination regarding melanoma showed that BTLA+ CD8+ tumor-infiltrating lymphocytes (TILs) showed a superior response and better survival compared to BTLA- CD8+ TILs (65) as BTLA plays a costimulatory role on activating CD8+ T-cells in melanoma. This evidence concerns the gene BTLA and neoplasm.